GL1X · GenesisL1 explorer

MolNFT v1 · #167011 · protein

Crystal structure of ctx-M-14 E166A/P167S/D240G beta-lactamase in complex with ceftazidime-1

6V83: “Crystal structure of ctx-M-14 E166A/P167S/D240G beta-lactamase in complex with ceftazidime-1”. X-ray diffraction, 1 ligand (CAZ), 1 pocket (best druggability 0.33). MolNFT v1 #167011 on GenesisL1: 3D structure, binding sites and…

PDB
6V83
Type
protein
Length
261 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9L5C7
Ligands
CAZ
Pockets
1 · best druggability 0.33

Structure

x-ray diffraction · 1 distinct chain · 44% helix, 20% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein26144% helix, 20% strandQ9L5C7

Ligands and binding sites

  • CAZ · Acylated ceftazidime · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1770.330.7520CAZ

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6V83 · Crystal structure of CTX-M-14 E166A/P167S/D240G beta-lactamase in complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.